Clinical Trials

Accrual Status
Limit to SWOG Trials

1030 Results

    View
    Status Trial Number Title Activated Closed Accrual Phase Published
    Closed S0124 Cis/Irinotecan vs. Cis/VP-16 in Extensive SCLC 11/1/2002 3/1/2007 99% Published
    Closed S0023 Cis/VP-16/RT/Consol. Doc followed by ZD1839/Placebo /IIIA & selected IIIB NSCLC 6/15/2001 4/15/2005 74% Published
    Closed S0220 Cis/VP-16/RT/Surgery/Doc/Selected IIB, Stage IIIA or IIIB (Pancoast Tumors) 7/1/2003 10/1/2007 92% Published
    Closed S0122 Cisplat/Etopo/RT followed by Cisplat/Etopo/TriAb & TriGem Vaccines in Limited SCLC 12/15/2002 5/15/2003 10%
    Closed SWOG-8850 Cisplatin and Novobiocin in the Treatment of Stage IV, Stage IIIb or Locally Recurrent Tumor After Radiation Therapy of Non-Small Cell Lung Cancer (NSCLC) 8/15/1988 6/1/1990 72% Published
    Closed S0533 Cisplatin/Etoposide/RT/Docetaxel and Three Cohorts of Bevacizumab-Advanced Stage III NSCLC 6/15/2006 3/1/2010 16% Published
    Closed SWOG-8901 Clinical Trial of the Most Active Drugs Selected by Clonogenic Assay to be Administered by the Intrahepatic Arterial Route for Colorectal Cancer Metastatic to the Liver 9/1/1990 10/15/1991 5%
    Closed SWOG-8897 CMF vs. CAF ± Tamoxifen in High-Risk, Node Neg. 7/15/1989 2/1/1993 100% Published
    Closed SWOG-7725 CMFP vs. CMFP + Levamisole for ER-Patients with Breast Cancer 10/10/1977 7/24/1980
    Closed SWOG-7436 CMFVP vs Melphalan for operable breast cancer 1/9/1975 7/18/1979 100% Published
    Closed SWOG-8014 Colchicine in Refractory Chronic Lymphocytic Leukemia 7/7/1980 10/23/1981
    Closed SWOG-7960 Colchicine in Refractory Hodgkin's Disease, CLL, Lung and Breast Cancer 2/28/1979 7/7/1980
    Closed SWOG-9419 COLORECTAL 3/15/1995 8/15/2001
    Closed S9635 COLORECTAL 4/1/1998 9/15/2000 49% Published
    Closed S9923 COLORECTAL 6/1/2000 8/1/2001 100% Published
    Closed S0030 COLORECTAL 2/1/2003 2/1/2005 48% Published
    Closed S0303 COLORECTAL 4/1/2004 9/1/2004 2%
    Closed S0336 COLORECTAL 4/15/2004 9/1/2005 70% Published
    Closed S0408 COLORECTAL 11/15/2006 4/1/2007 0%
    Closed S0600 Colorectal Ph III irinotecan-based chemo + cetuximab or bevacizumab 6/15/2007 11/10/2010 11% Published
    Scroll Table